Arizona 2025 Regular Session

Arizona Senate Bill SB1200

Introduced
1/23/25  
Report Pass
2/17/25  
Report Pass
2/24/25  

Caption

Mandated health coverage; JLBC; analysis

Summary

SB1200 makes technical and substantive changes to Arizona’s laws governing mandated health coverage proposals and cost-sharing restrictions. Under current law, anyone advocating a bill that would require a health insurance benefit or limit cost sharing must submit a report evaluating the proposal’s social and financial effects. This bill updates the required factors that must be considered in that analysis, including whether the service is widely used, whether coverage already exists, whether lack of coverage causes people to delay care or face financial hardship, public demand, and interest from collective bargaining agents. The bill also expands and clarifies the financial-impact analysis. It requires consideration of effects on treatment costs, utilization, substitution for more expensive care, insurer and policyholder administrative expenses, total health care costs, impacts on other policyholders, and whether Arizona would have to pay any additional federal marketplace subsidy costs. The bill specifies that an actuary who is a member of the American Academy of Actuaries must prepare and certify the financial analysis, and it requires the report to address the specific language of the proposed mandate rather than relying on a similar report from another jurisdiction. It also states that failure to submit the report does not create civil or criminal penalties.

Impact

SB1200 would amend A.R.S. sections 20-181 and 20-182, affecting the process used to evaluate proposed health insurance mandates and cost-sharing restrictions in Arizona. It does not directly mandate any new insurance benefit, but it changes the analytical requirements that must accompany future proposals, which could influence how easily such mandates advance and how lawmakers assess their fiscal and policy consequences. The bill primarily affects advocates of mandated coverage, insurers, actuaries, and legislators considering health insurance benefit mandates.

Sentiment

The bill appears to have received mixed but generally workable support in the Senate process. It advanced through committee and passed third reading 17-12, suggesting meaningful support but also notable opposition. The lack of recorded committee transcript discussion limits insight into detailed arguments, but the vote pattern indicates the measure was not broadly unanimous and likely drew debate over whether the added analysis requirements improve transparency or create additional hurdles for mandate proposals.

Contention

The main point of contention is likely the bill’s effect on future health coverage mandates. Supporters may view the updated factors and actuarial certification as a way to improve rigor, transparency, and cost awareness before new insurance requirements are enacted. Opponents may see the bill as adding procedural burdens that could make it harder to advance mandated benefits or cost-sharing protections, especially by requiring more detailed, proposal-specific analysis and an actuary-certified financial review. The requirement to analyze potential impacts on premiums, other policyholders, and federal subsidy obligations is also likely to be a focal point because it emphasizes cost concerns.

Companion Bills

No companion bills found.

Similar Bills

CA SB824

Secure youth treatment facilities.

WA SB6296

Concerning involuntary treatment.

NJ A1821

Prohibits health insurance carriers from denying coverage of nonopioid prescription drugs in favor of opioid prescription drugs.

CA SB1157

Juveniles: secure youth treatment facilities: less restrictive programs.

NM SB390

Health Services Reimbursement

NJ S4283

Prohibits health insurance carriers from denying coverage of nonopioid prescription drugs in favor of opioid prescription drugs.

MS SB2388

Medicaid; create provisions effecting parity in the prescription of pain medication.

NV AB167

Revises provisions relating to the use of corrective room restriction. (BDR 5-769)